Keisuke Suzuki1, Takao Takeshima2, Hisaka Igarashi3, Noboru Imai4, Daisuke Danno2, Toshimasa Yamamoto5, Eiichiro Nagata6, Yasuo Haruyama7, Takashi Mitsufuji5, Shiho Suzuki8, Yasuo Ito5, Mamoru Shibata9, Hisanori Kowa10, Shoji Kikui2, Tomohiko Shiina8, Madoka Okamura8, Muneto Tatsumoto11, Koichi Hirata8. 1. Department of Neurology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsuga, 321-0293, Tochigi, Japan. keisuke@dokkyomed.ac.jp. 2. Department of Neurology, Headache Center, Tominaga Hospital, Osaka, Japan. 3. Department of Internal Medicine, Headache Care Unit, Fujitsu Clinic, Kanagawa, Japan. 4. Department of Neurology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan. 5. Department of Neurology, Saitama Medical University, Saitama, Japan. 6. Department of Neurology, Tokai University School of Medicine, Kanagawa, Japan. 7. Integrated Research Faculty for Advanced Medical Science, Dokkyo Medical University School of Medicine, Tochigi, Japan. 8. Department of Neurology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsuga, 321-0293, Tochigi, Japan. 9. Department of Neurology, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan. 10. Department of Neurology, National Hospital Organization, Matsue Medical Center, Shimane, Japan. 11. Medical Safety Management Center, Dokkyo Medical University Hospital, Tochigi, Japan.
Abstract
OBJECTIVES: To assess the impacts of social situation changes due to the coronavirus disease 2019 (COVID-19) pandemic on headache-related disability and other symptoms in patients with migraine in Japan. METHODS: We conducted a multicentre, cross-sectional study including 659 outpatients with migraine diagnosed by headache specialists. The participants were asked about the impacts of the first wave of the COVID-19 pandemic on headache-related disability, headache days, headache intensity, stress, physical activity, hospital access and their work and home lives. For headache-related disability, the total Migraine Disability Assessment (MIDAS) score and part A and B scores were analysed. Multivariate stepwise linear regression analysis was performed to identify the clinical predictors of changes in the total MIDAS score before and during the COVID-19 pandemic. Logistic regression analysis was performed to determine the factors related to new-onset headache during the COVID-19 pandemic. RESULTS: Finally, 606 migraine patients (73 M/533 F; age, 45.2 ± 12.0 years) were included in the study, excluding those with incomplete data. Increased stress, substantial concern about COVID-19 and negative impacts of the first wave of the COVID-19 pandemic on daily life were reported in 56.8 %, 55.1 and 45.0 % of the participants, respectively. The total MIDAS and A and B scores did not significantly change after the first wave of the COVID-19 pandemic. New-onset headache, which was observed in 95 patients (15.7 %), was associated with younger age and worsened mood and sleep in the logistic regression analysis. The multivariate stepwise linear regression analysis of changes in the total MIDAS score before and during the first wave of COVID-19 pandemic identified worsened sleep, increased acute medication use, increased stress, medication shortages, comorbidities, the absence of an aura and new-onset headache were determinants of an increased total MIDAS score during the first wave of the COVID-19 pandemic. CONCLUSIONS: In this multicentre study, clinical factors relevant to headache-related disability, such as new-onset headache, stress and sleep disturbances, were identified, highlighting the importance of symptom management in migraine patients during the first wave of the COVID-19 pandemic.
OBJECTIVES: To assess the impacts of social situation changes due to the coronavirus disease 2019 (COVID-19) pandemic on headache-related disability and other symptoms in patients with migraine in Japan. METHODS: We conducted a multicentre, cross-sectional study including 659 outpatients with migraine diagnosed by headache specialists. The participants were asked about the impacts of the first wave of the COVID-19 pandemic on headache-related disability, headache days, headache intensity, stress, physical activity, hospital access and their work and home lives. For headache-related disability, the total Migraine Disability Assessment (MIDAS) score and part A and B scores were analysed. Multivariate stepwise linear regression analysis was performed to identify the clinical predictors of changes in the total MIDAS score before and during the COVID-19 pandemic. Logistic regression analysis was performed to determine the factors related to new-onset headache during the COVID-19 pandemic. RESULTS: Finally, 606 migrainepatients (73 M/533 F; age, 45.2 ± 12.0 years) were included in the study, excluding those with incomplete data. Increased stress, substantial concern about COVID-19 and negative impacts of the first wave of the COVID-19 pandemic on daily life were reported in 56.8 %, 55.1 and 45.0 % of the participants, respectively. The total MIDAS and A and B scores did not significantly change after the first wave of the COVID-19 pandemic. New-onset headache, which was observed in 95 patients (15.7 %), was associated with younger age and worsened mood and sleep in the logistic regression analysis. The multivariate stepwise linear regression analysis of changes in the total MIDAS score before and during the first wave of COVID-19 pandemic identified worsened sleep, increased acute medication use, increased stress, medication shortages, comorbidities, the absence of an aura and new-onset headache were determinants of an increased total MIDAS score during the first wave of the COVID-19 pandemic. CONCLUSIONS: In this multicentre study, clinical factors relevant to headache-related disability, such as new-onset headache, stress and sleep disturbances, were identified, highlighting the importance of symptom management in migrainepatients during the first wave of the COVID-19 pandemic.
Authors: Christina L Szperka; Jessica Ailani; Rebecca Barmherzig; Brad C Klein; Mia T Minen; Rashmi B Halker Singh; Robert E Shapiro Journal: Headache Date: 2020-04-03 Impact factor: 5.311
Authors: Rehab Magdy; Alaa Elmazny; Shaimaa H Soliman; Eman H Elsebaie; Sara H Ali; Ali M Abdel Fattah; Mahmoud Hassan; Ahmed Yassien; Noha A Mahfouz; Radwa M Elsayed; Wael Fathy; Hoda M Abdel-Hamid; Jehan Mohamed; Mona Hussein Journal: J Headache Pain Date: 2022-08-12 Impact factor: 8.588